The role of genetic polymorphisms in cytochrome P450 and effects of tuberculosis co-treatment on the predictive value of CYP2B6 SNPs and on efavirenz plasma levels in adult HIV patients-Reference-Cited by-同舟云学术

The role of genetic polymorphisms in cytochrome P450 and effects of tuberculosis co-treatment on the predictive value of CYP2B6 SNPs and on efavirenz plasma levels in adult HIV patients

Published:2014-02 Issue: Volume:102 Page:44-53
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Bienvenu Emile,Swart Marelize,Dandara Collet^ORCID,Ashton Michael

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference41 articles.

1. Antiretroviral therapy for HIV-associated tuberculosis;Avihingsanon;Asian Biomed.,2009

2. Glucuronidation of the antiretroviral drug efavirenz by UGT2B7 and an in vitro investigation of drug–drug interaction with zidovudine;Bélanger;Drug Metab. Dispos.,2009

3. A rapid and selective HPLC–UV method for the quantitation of efavirenz in plasma from patients on concurrent HIV/AIDS and tuberculosis treatments;Bienvenu;Biomed. Chromatogr.,2013

4. Frequencies of single nucleotide polymorphisms in cytochrome P450 genes (CYP1A2, 2A6, 2B6, 3A4, and 3A5) in a Rwandan population: difference to other African populations;Bienvenu;Curr. Pharmacogenomics Person Med.,2013

5. Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis;Burman;Clin. Infect. Dis.,1999

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics and adverse effects of anti‐infective drugs in children;Clinical and Experimental Pharmacology and Physiology;2023-10-15

2. Late-onset efavirenz toxicity: A descriptive study from Pretoria, South Africa;Southern African Journal of HIV Medicine;2023-01-12

3. Late-onset efavirenz toxicity: A descriptive study from Pretoria, South Africa;Southern African Journal of HIV Medicine;2022-10-31

4. Pharmacogenetics of Breast Cancer Treatments: A Sub-Saharan Africa Perspective;Pharmacogenomics and Personalized Medicine;2022-06

5. Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana;Pharmacogenomics and Personalized Medicine;2021-03